Dr. Elena Ratner discusses the interaction between menopause and certain treatments for breast cancer.
Elena Ratner, MD, of the Smilow Cancer Hospital at Yale, explains the interaction between menopause in women and treatments for breast cancer.
Treatments such as radiation, chemotherapy, and certain hormonal agents can affect menopause and induce it more severely in patients with breast cancer. However, Ratner suggests a number of options to help with this, including herbal medications and integrative therapies such as exercise or acupuncture. With the Sexual Intimacy & Menopause Program at Smilow, Ratner provides personalized care to patients with menopause-related issues.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.